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Abstract
This study investigated the effect of sildenafil citrate on micro-recanalization and neovascularization, which 
were previously demonstrated in a rat model using biodegradable grafts (BGs) for vas deferens reconstruction.  A 
total of 24 male rats underwent bilateral vasectomy with removal of a 0.5-cm vasal segment and were randomly 
assigned to four groups.  Groups 1 and 2 underwent immediate vasovasostomy.  Groups 3 and 4 underwent 
interposition of a 0.5-cm BG in the vasal gap.  Groups 1 and 3 were given 5 mg kg−1 day−1 oral sildenafil.  Other 
groups were given placebo.  Rats were housed with females 12 weeks postoperatively.  Reconstructed vasal 
segments were harvested 16 weeks postoperatively and analyzed histologically.   Fluid from the distal vasal stump 
was analyzed for motile sperm.  Urine samples obtained 16 weeks postoperatively were analyzed for cGMP levels. 
cGMP levels in rats treated with sildenafil were significantly higher than in control rats.  No pregnancies were sired 
by grafted groups.  In all, 5/6 rats in group 1 and 3/6 rats in group 2 sired litters.   No motile sperm were noted in 
the vasal fluid of the grafted groups.  Motile sperm were noted in all rats in group 1 and in 5/6 rats in group 2.  In 
addition, 29 and 4 microcanals were detected in the sildenafil and placebo groups, respectively (P = 0.023).  No 
microcanal exceeded 3 mm in length.  An average of 12 and 28 blood vessels per graft were noted in the placebo 
and sildenafil groups, respectively (P < 0.0001).  In conclusion, sildenafil enhances micro-recanalization and 
neovascularization in BG used for vas deferens reconstruction, but does not increase the microcanal length after 16 
weeks.
Asian Journal of Andrology (2010) 12: 814–818.  doi: 10.1038/aja.2010.55;  published online 19 July 2010.
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1    Introduction
Obstructive azoospermia (OA) is a significant entity 
in male infertility, estimated to account for up to 40% 
of azoospermia cases.  Obstruction may be present at 
various levels along the course of the male reproductive 
tract, including the epididymis, the vas deferens and the 
ejaculatory ducts.  OA may be secondary to congenital 
disorders, such as congenital bilateral absence of the 
vas deferens, commonly associated with cystic fibrosis, 
as well as to partial vasal absence.  Obstructive lesions 
leading to azoospermia may be acquired, secondary to 
scrotal or pelvic trauma, surgery and infection, causing 
fibrosis, scarring or frank disruption of the male genital 
tract.  The intentional interruption of the vas deferens 
during vasectomy is one of the most common causes for 
OA in the United States.  Bilateral vasectomy is performed 
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on nearly 500 000 men every year in the United States 
[1].  Vasectomy reversal is performed in nearly 6% of men 
who had a vasectomy [2].  Furthermore, approximately 
6% of men who suffer iatrogenic injury to the vas deferens 
require reconstruction [3].
The aim of reconstructive surgery for OA is to 
regain continuity of the obstructed male genital tract, 
thus allowing for reappearance of sperm in the ejaculate 
and, eventually, achievement of natural conception. 
The preferred reconstructive technique involves the 
identification and isolation of the obstructed site, 
and resection of the obstructed segment followed 
by primary anastomosis of the edges of the genital 
tract on both sides of the obstructed segment, after 
confirming the patency of the tract distal and proximal 
to the obstruction.   However, the presence of long 
obstructed or missing segments might preclude the 
accomplishment of such an anastomosis, or put it under 
tension that could cause disruption or leakage.
Tissue engineering strategies using biodegradable 
polymer scaffolds have been studied for regeneration of 
various tissues and organs such as skin, cartilage, liver 
and peripheral nerves.  We have previously explored 
the feasibility of adapting this concept for treatment of 
OA, and investigated the possible use of biodegradable 
polymer grafts (Figure 1) in reconstructive procedures 
involving long obstructed or missing segments of 
the male reproductive tract [4].  We were able to 
demonstrate early evidence of post-vasectomy micro-
recanalization through plain biodegradable grafts (BGs) 
that were devoid of any chemical or biological cues. 
These microcanals may be similar to those described by 
Freund et al. [5] in previous vasectomy sites removed 
at the time of vasovasostomies.
Sildenafil citrate is a phosphodiesterase inhibitor 
that was initially developed as an anti-hypertensive and 
anti-angina agent.  Clinical trials showed little effect on 
angina but the drug induced penile erections and has 
subsequently been marketed for erectile dysfunction 
(ED).  Sildenafil is a selective inhibitor of cGMP-
specific phosphodiesterase type 5.  In addition to 
mediating relaxation of the corporal smooth muscle, 
cGMP is involved in many other cellular signaling 
pathways mediated by cGMP-gated ion channels and 
cGMP-dependent protein kinases.  cGMP has been 
implicated in post-natal angiogenesis.  Sildenafil 
citrate leads to increased vascular endothelial growth 
factor expression and angiogenesis in a rat model of 
coronary ischemia [6].  In addition, administration of 
oral sildenafil citrate improved recovery of spontaneous 
‘normal’ erections following radical prostatectomy 
in a controlled study [7].  It was postulated that this 
effect may be the result of improved endothelial 
function combined with neuronal regeneration and 
neuroprotection.  Sildenafil also increases brain levels 
of cGMP, evokes neurogenesis and reduces neurological 
deficits when given to rats 2 or 24 h after stroke [8].
We therefore hypothesized that administration of 
sildenafil citrate would lead to enhanced neovascularity 
and microcanal formation in implanted biodegradable 
vas deferens grafts.
2    Materials and methods
The BGs used in this study were designed and 
constructed at Iowa State University (Ames, IA, USA). 
Porous conduits for grafting were made of PDLA 
(DURECT, Birmingham Polymers [Pelham, AL] Lactel 
Poly-DL-lactide, inherent viscosity 63 mL g−1 in CHCl3 
at 30 ºC).  Poly-DL-lactide was dissolved in chloroform 
at 30% w/v.  Sodium chloride was ground in a mortar 
and pestle and sieved through a #140 (106 µm) mesh. 
Sieved NaCl was added to the polymer/chloroform 
solution to obtain finished conduits with 75% porosity. 
Polyvinyl alcohol-coated glass capillary tubes were 
dipped into the PDLA/salt suspension.  Tubes were 
soaked in water to remove NaCl and polyvinyl alcohol 
and conduits were dried in a desiccator.  Desiccated 
conduits were stored in sampling tubes at 4 ºC.
Micropatterned PDLA films were inserted into each 
Figure 1.  Scanning electron microscope image of a polymer 
graft [4]. 
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conduit with the micropatterned luminaly exposed. 
Four-inch micropatterned silicon casts were used to 
make the micropatterned films.  The micropattern was 
fabricated on wafers using ultraviolet lithography and 
reactive ion etching as described by Recknor et al. 
[9].  The micropattern consisted of parallel ridges with 
height, thickness and separation of 4, 14 and 16 µm, 
respectively.  Wafers were spin-coated with 5% w/v 
polyvinyl alcohol dissolved in water and then the 30% 
PDLA solution, allowing sufficient drying time after 
coatings.  Wafers were submerged in 18 mΩ filtered 
water (Nanopure; Thermo Scientific, Waltham, MA, 
USA) to dissolve the PVA layer and detach films from 
the wafer.  Sections were then cut out of the film, rolled 
up against a capillary tube and inserted into the conduits 
with the pattern aligned longitudinally with the conduits.
The study protocol was approved by the Institutional 
Animal Care and Use Committee of the University 
of Iowa.  A total of 24 male Sprague–Dawley rats 
were used.  Rat age at arrival was 2 months with a 
weight range of 225–249 g (Harlan Laboratories Inc., 
Indianapolis, IN, USA).
Rats were randomly assigned to four groups with 
six in each group.  All animals underwent bilateral 
vasectomy under general anesthesia with intraperitoneal 
sodium pentobarbital through a low midline abdominal 
incision.  A 0.5-mm segment of vas was removed on 
both sides.  Groups 1 and 2 underwent immediate 
end-to-end vasovasostomy with 10-0 nylon suture. 
Groups 3 and 4 underwent microsurgical interposition 
of a 0.5-mm PDLA graft in end-to-end fashion to re-
approximate the vas deferens with 10-0 nylon suture.
Groups 1 and 3 were given 5 mg kg−1 daily oral 
sildenafil citrate (mixed into peanut butter balls) for 
16 weeks while groups 2 and 4 were given placebo. 
Twelve weeks after vasectomy and reconstruction, each 
male rat was housed with a female rat for a period of 10 
days, which corresponds to about two estrous cycles of 
the female rat.  If pregnancy did not occur, the female 
rat was transferred to the next male’s cage.
At 16 weeks after vasectomy and reconstruction, 
a urine sample was obtained by suprapubic aspiration 
and immediately frozen on a dry ice and 95% ethanol 
slurry for later analysis.  The reconstructed segments of 
vas were harvested and placed in formalin.  A sample 
of vasal fluid from the abdominal end of the vas was 
obtained and mixed with one drop of phosphate-
buffered saline for immediate identification of motile 
sperm by light microscopy.  The animals were then 
killed by lethal intraperitoneal injection of pentobarbital 
and confirmed dead by thoracotomy.
Rat urine samples were analyzed for cGMP levels by 
enzyme-linked immunosorbant assay in accordance with 
the manufacturer’s protocol (Cell Biolabs, San Diego, 
CA, USA).  This cGMP assay is designed to measure 
cGMP in cell culture supernatants, plasma, serum, saliva, 
urine and cell lysates.  The kit selectively measures 
cGMP levels without any significant cross-reactivities 
to other nucleotides or cyclic nucleotides.  The kit has a 
detection range of 1 to 1 000 pmol mL−1 cGMP.   
Harvested PDLA grafts were serially sectioned at 1-mm 
intervals and stained with hematoxylin and eosin (H&E) 
for microscopic analysis by a single pathologist who was 
blinded to the treatment groups.  Representative sections 
were also stained for CD31 (PECAM-1) for definitive 
identification and quantification of endothelial-lined 
vessels.  The final count of these vessels was calculated 
by averaging two separate countings at least 24 h apart.
The rats were housed in horizontal Thoren (Hazleton, 
PA, USA) 12″ × 12″ #4 Udel cages maintained at 22.2 ºC. 
One rat was housed per cage unless breeding, at which 
time one male and one female were housed together. 
Bedding was SoftZorb paper-based laboratory bedding 
(Northeastern Product Corp., Warrensburg, NY, USA). 
Feed was NIH-31 modified 6% mouse/rat sterilizable 
diet #4913.  Water was filtered.  Statistical analysis was 
performed using the Wilcoxon rank-sum test with P < 0.05 
considered as statistically significant.
3    Results
cGMP levels in rats treated with 16 weeks of oral 
sildenafil citrate were significantly higher compared 
with the placebo group (Wilcoxon rank-sum test, P = 0.008). 
The sildenafil group had a median cGMP level of 
191.5 pmol mL−1 compared with 59.0 pmol mL−1 in the 
placebo group (Table 1).
No pregnancies were sired by any rat with implanted 
PDLA grafts.  Five of six rats in the primary vasovasostomy 
group were treated with sildenafil sired litters and three 
Table 1.  Distribution of cGMP levels (pmol mL-1) in rats treated 
with 16 weeks of oral sildenafil citrate vs. controls.
Treatment N        Median     25th percentile   75th percentile
Placebo 6   59.0   32.0   78.0
Sildenafil 6 191.5 188.0 223.0
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of six rats in the primary vaso-vasostomy group were 
treated with placebo sired litters.
No motile sperm was observed in the distal vasal 
fluid of rats in the grafted groups.  Motile sperm was 
present in six of six rats in the sildenafil group and in 
five of six rats in the placebo group.
At 16 weeks, all PDLA grafts were easily identifi-
able, grossly intact and sealed to the vas at both ends. 
Histological examination of the PDLA grafts revealed 
the presence of a granulomatous inflammatory response 
within the lumens.  Also identified were multiple 
microcanals lined with a distinct layer of cuboidal 
epithelial cells within the lumens of the grafts.  A total 
of 29 microcanals were identified in the sildenafil 
groups and four microcanals were identified in the 
placebo groups.  The average microcanal length was 
2 mm.  None of the 33 microcanals exceeded 3 mm in 
length.  Wilcoxon rank-sum test showed a significantly 
greater number of microcanals in the sildenafil group 
compared with placebo (P = 0.023).  Of the 12 rats 
in the sildenafil group, there were 6 (50%) that had 
two or more microcanals and four (33%) with no 
microcanals.  In the placebo group, there was only one 
(17%) that had two or more microcanals and nine (75%) 
with no microcanals.   Similar results were found if 
type of vasectomy was accounted for in the analysis 
(Cochran–Mantel–Haenszel statistic based on rank 
scores, P = 0.014).  In the sildenafil group, two or more 
microcanals were found in four of six (67%) that had 
vasovasostomy and two of six (33%) that had PDLA 
grafts.  In contrast, in the placebo group, only one of six 
(17%) in those with vasovasostomy and none of six in 
those with PDLA grafts had two or more microcanals 
(Table 2).
A large number of small blood vessels were identi-
fied on H&E staining throughout the walls and lumens 
of the PDLA grafts.
CD31 staining of the PDLA grafts confirmed the 
presence of endothelial-lined vessels in their walls and 
lumens.  Wilcoxon rank-sum test showed a significantly 
greater number of stained vessels in the sildenafil group 
compared with placebo (P < 0.0001).  The median 
number of stained vessels in the sildenafil group was 
29 compared with 11.5 in the placebo group.  Similar 
results were found if type of vasectomy was accounted 
for in the analysis (Cochran–Mantel–Haenszel statistic 
based on rank scores, P < 0.0001) (Table 3).
4    Discussion
Reconstruction of the vas deferens in the setting 
of a long segment of obstruction remains a challenge 
when primary repair is not an option.  We previously 
demonstrated that reconstruction of the vas with a 
Table 2.  Comparison of the number of microcanals between placebo and sildenafil.
Number of canals
                        Placebo, n (%)                                                                 Sildenafil, n (%)              
P-value
  Vasovasostomy   PDLA   All Vasovasostomy         DLA                 All
   0       4 (67)   5 (83) 9 (75)       1 (17)      3 (50) 4 (33) 0.014a
   1       1 (17)   1 (17) 2 (17)       1 (17)      1 (17) 2 (17) 
   2       1 (17)   0 (0) 1 (17)       0 (0)      2 (33) 2 (17) 
> 2       0 (0)   0 (0) 0 (0)       4 (67)      0 (0) 4 (33) 
Abbreviation: PDLA, poly-D-lactide.
aCohran–Mantel–Haenszel statistic based on rank scores, adjusting for type of vasectomy. 
Table 3.  Comparison of the number of CD31-stained vessels between placebo and sildenafil groups.
Type of vasectomy
                                   Placebo                                                                Sildenafil                                          
P-value
          Median        25th–75th percentile         Median       25th–75th percentile 
Vasovasostomy 11.5    11–14 28.5 27–34 < 0.0001a
PDLA 11    10–12 29.5 23–32 
All 11.5 10.0–12.5 29 25–33 < 0.0001b
Abbreviation: PDLA, poly-D-lactide.
aCohran–Mantel–Haenszel statistic based on rank scores, adjusting for type of vasectomy.  bWilcoxon rank-sum test.
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biodegradable PDLA graft in a rat model led to some 
cases of microrecanalization as early as 12 weeks 
after implantation [4].  All cases showed evidence of 
neovascularization.  We therefore sought to improve 
neovascularization of the PDLA graft with the aim of 
increasing the rate of microcanal formation.
As a type 5 phosphodiesterase inhibitor, sildenafil 
citrate has been marketed as a successful agent in the 
treatment of both ED and pulmonary hypertension. 
Its mechanism of action involves inhibition of the 
breakdown of cyclic GMP, which in turn leads to 
local vasodilation.  Recently, sildenafil has also been 
shown to increase expression of vascular endothelial 
growth factor and angiopoietin-1, leading to increased 
neovascularization in a rat model of coronary ischemia 
and promoting functional recovery after stroke in a rat 
model of cerebral ischemia [6, 8].
Although the current study demonstrated increased 
neovascularity within PDLA grafts in the sildenafil group 
as well as a significantly increased number of microcanals, 
none of these canals extended the length of the grafts, 
no motile sperm were observed in smears from the 
distal ends of the grafts and none of the grafted animals 
were able to achieve a pregnancy, which is the ultimate 
outcome of a successful reconstruction of an obstructed 
vas deferens.  This is likely secondary to obliteration 
of the graft lumen by an intense inflammatory reaction, 
which is only later followed by neovascularization and 
ultimately, recanalization.  Sixteen weeks may simply not 
be a sufficient time period to allow this process to extend 
the length of the 0.5-cm graft despite the use of sildenafil. 
A functional obstruction may also exist within the lumen 
of the graft, as this segment lacks smooth muscle and is 
therefore not capable of peristalsis.
Future studies will be necessary to investigate the 
effect of a longer period of time after graft implantation 
on the patency of the PDLA graft, the extent of micro-
recanalization and the ability to achieve pregnancy 
following this type of reconstruction.  Studies are 
also planned to investigate whether the addition of 
selected growth factors to the grafts in combination 
with systemic sildenafil could enhance microcanal 
formation and length.  Finally, the fact that the 
sildenafil citrate induced an increase in post-vasectomy 
neovascularity and micro-recanalization, which has 
been demonstrated in this study, raises the question of 
whether the use of this medication after vasovasostomy 
or vasoepididymostomy in human subjects could lead 
to improved patency and pregnancy outcomes of these 
procedures.  Investigation of this interesting possibility 
is beyond the scope of this study, and would require 
separate future research.
In conclusion, sildenafil citrate stimulates neovascu-
larity and the formation of microcanals in PDLA grafts 
used to reconstruct the vas deferens in a rat model but 
does not increase microcanal length after 16 weeks.
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